Form 4 for ASTH Astrana Health, Inc.
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-16 · accession 0001104659-24-063017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-16 | ASTH | Basho Chandan | COO, CFO | F - Tax | $41.13 | -7,051 | 151.2K | -4% | -$290.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | F | D | 7,051 | $41.13 | 151,232 | D | — | — | (F1) Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock. (F2) Includes 64,594 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which vest on May 16, 2025; and (iii) 45,606 shares, which vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes 15,692 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer). |